Biagio Ricciuti: The association of automatically extracted body composition metrics with IO efficacy in mNSCLC

Biagio Ricciuti, recently posted on X:

“Out in JAMA Oncology!

Our effort to determine the association of automatically extracted body composition metrics with immunotherapy efficacy in patients with metastatic NSCLC.

Skeletal muscle loss and changes in subcutaneous adipose tissue are important dynamic prognostic factors.

Led by Tafadzwa L. Chaunzwa and Hugo Aerts. With João Alessi, Alessandro Di Federico, Mark Awad, and many others.”

Read further
Source: Biagio Ricciuti/X

Biagio Ricciuti is a thoracic oncologist at the Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. His research interests are various aspects of lung cancer, including novel therapeutics, biomarker identification, and predictive modeling for patient outcomes. Besides being actively engaged in research, Dr. Ricciuti is involved in clinical trials and patient care.